There is a great variability in testing for monoclonal gammopathies. During his presentation, Dr. David F. Keren, MD, Clinical Professor of Pathology at University of Michigan Health, describes the use of Free Light Chains in detecting monoclonal gammopathies.
Learning Objectives:
- Name five types of immunoglobulin heavy chains and two types of immunoglobulin light chains.
- State specific advantage(s)/disadvantage(s) of serum free light chain assessment.
- Identify three platforms on which the serum free light chain assay currently can be run.
- State three pathologies detectable by serum free light chain assessment.
- Identify a possible additional use for serum free light chain assessment.
Speaker
David F. Keren, M.D. Clinical Professor, Pathology & Immunopathology University of Michigan Health
Dr. David Keren is a renowned expert on monoclonal gammopathies, serum protein abnormalities and evaluation of hemoglobinopathies. He received his B.S., M.S. and M.D. degrees from the University of Illinois. He completed his residency training in Anatomic and Clinical Pathology and postdoctoral training in Immunopathology and Immunohematology at The Johns Hopkins Hospital. Dr. Keren joined the Department of Pathology of the University of Michigan in 1978. He has authored over 160 peer-reviewed articles and has written or edited 13 books. Currently, he is a Trustee of the American Board of Pathology and a member of the CAP Hematology and Clinical Microscopy Resource Committee.
